Lates News

date
21/01/2026
GlaxoSmithKline fell 0.3% in early trading on Tuesday. The company has agreed to acquire RAPT Therapeutics, which will add the long-acting anti-IgE antibody ozureprubart for food allergies to its immunology product line.
Latest
See all latestmore